JelĂnková, Lucie
Flores-Garcia, Yevel
Shapiro, Sarah http://orcid.org/0000-0002-2246-3319
Roberts, Bryce T.
Petrovsky, Nikolai http://orcid.org/0000-0002-1580-5245
Zavala, Fidel http://orcid.org/0000-0002-1414-6196
Chackerian, Bryce http://orcid.org/0000-0002-5712-4739
Funding for this research was provided by:
Jeffrey Michael Gorvetzian Endowment for Biomedical Excellence
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHS-N272201400053C, HHS-N272200800039C, U01-AI061142)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Bloomberg Philanthropies
Article History
Received: 30 August 2021
Accepted: 4 February 2022
First Online: 8 March 2022
Competing interests
: B.C. has equity in FL72, a company that does not have financial interest in malaria vaccines. N.P. is affiliated with Vaxine Pty Ltd, a company having a financial interest in Advax adjuvants. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.